Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec;46 Suppl 6(Suppl 6):S346-S361.
doi: 10.1016/j.htct.2024.11.119. Epub 2024 Dec 18.

Management of febrile neutropenia: consensus of the Brazilian Association of Hematology, Blood Transfusion and Cell Therapy - ABHH

Affiliations

Management of febrile neutropenia: consensus of the Brazilian Association of Hematology, Blood Transfusion and Cell Therapy - ABHH

Marcio Nucci et al. Hematol Transfus Cell Ther. 2024 Dec.

Abstract

Febrile neutropenia is a major complication of the treatment of patients with hematologic diseases. Recent epidemiologic changes, with an increase in infection caused by drug-resistant bacteria, represent a major challenge for the proper management of febrile neutropenia. The impact of these changes in the epidemiology of infection may vary according to the region. In this document we present recommendations from the Infectious Diseases Committee of the Brazilian Association of Hematology, Blood Transfusion and Cell Therapy (ABHH) for the management of febrile neutropenia in hematologic patients. The consensus was developed by ten experts in the field, using the Delphi methodology. In the document we provide recommendations for the initial workup, prophylaxis, empiric antibiotic and antifungal therapy, modifications in the empiric regimen and criteria for discontinuing antimicrobial therapy.

Keywords: Consensus; Febrile neutropenia; Management; Neutropenia; Treatment.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest None.

Similar articles

Cited by

References

    1. Bodey G.P., Buckley M., Sathe Y.S., Freireich E.J. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med. 1966;64(2):328–340. - PubMed
    1. Bucaneve G., Micozzi A., Menichetti F., Martino P., Dionisi M.S., Martinelli G., et al. Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. N Engl J Med. 2005;353(10):977–987. - PubMed
    1. Alexander S., Fisher B.T., Gaur A.H., Dvorak C.C., Villa Luna D., Dang H., et al. Effect of levofloxacin prophylaxis on bacteremia in children with acute leukemia or undergoing hematopoietic stem cell transplantation: a randomized clinical trial. JAMA. 2018;320(10):995–1004. - PMC - PubMed
    1. Yeshurun M., Vaxman I., Shargian L., Yahav D., Bishara J., Pasvolsky O., et al. Antibacterial prophylaxis with ciprofloxacin for patients with multiple myeloma and lymphoma undergoing autologous haematopoietic cell transplantation: a quasi-experimental single-centre before-after study. Clin Microbiol Infect. 2018;24(7):749–754. - PubMed
    1. Reuter S., Kern W.V., Sigge A., Dohner H., Marre R., Kern P., et al. Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies. Clin Infect Dis. 2005;40(8):1087–1093. - PubMed

LinkOut - more resources